Skip to content
Search

Latest Stories

Spring Budget 2024: NHS England welcomes extra £2.45bn funding

Spring Budget 2024: NHS England welcomes extra £2.45bn funding

The government also announced a £3.4bn investment in capital to fund new technology to boost NHS productivity

UK Chancellor Jeremy Hunt presented the Spring Budget 2024 on Wednesday, making two big announcements for the NHS in England.


Hunt announced an additional £2.5 billion in day-to-day revenue funding for the fiscal year 2024/25 and another £3.4 billion to boost NHS productivity through a variety of tech-related investments.

Next year's health resource departmental expenditure limits (DEL) are set at £179.6 billion, with NHS England allocated £164.9 billion, marking an increase from this year's £163.2 billion.

NHSE welcomed the budget boost and appreciated the government's continued support for the service.

Responding to the budget, Amanda Pritchard, the Chief Executive of the NHS, said: “Today’s announcement shows the government continues to back the NHS and the £2.45bn of extra funding for next year ensures we have the support we need to make continued progress on our key priorities for patients.”

Pritchard added that the £3.4bn investment in capital to fund new technology will enable the NHS to commit to achieving 2 per cent annual productivity growth in the final two years of the next Parliament and unlock tens of billions of savings.

Through a variety of AI, digital and other tech-related measures, the government is anticipating to unlock £35 billion worth of savings from 2025-26 to 2029-30.

Of this £3.4 billion investment, £2 billion will be used to update “fragmented and outdated” IT systems across the NHS. This is expected to reduce 13 million hours wasted by doctors every year and enable up to £4 billion of savings over five years.

A £1 billion investment is earmarked for transforming “the use of data to reduce time spent on unproductive administrative tasks by NHS staff”, which is expected to help the health service save more than £3 billion over five years.

Another £430 million will be used to improve access and services for patients to facilitate savings of £6.5 billion over five years.

Hunt also announced a £35 million investment to be made by the government and the NHS over three years to improve maternity safety across England.

This new budget also included an additional funding of £45 million for medical research, with £3 million allocated for Cancer Research UK.

 

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less